Deciphera Pharmaceuticals, Inc. (DCPH) NASDAQ

25.59

+0.02(+0.08%)

Updated at June 10, 2024 04:00PM

Currency In USD

Valuation

Market Cap1.37B
Enterprise Value1.31B
P/E Ratio-11.17
PEG Ratio-3.93
Price/Sales Ratio13.55
Price/Book Ratio6.2
Enterprise/Revenue13.19
Enterprise/EBITDA-10.32

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterMarch 31, 2024

Profitability

Profit Margin-1.19
Operating Margin-1.29

Management Effectiveness

Return On Assets-0.41
Return On Equity-0.56

Income Statement

Revenue163.36M
Revenue/Share1.92
Gross Profit159.62M
EBITDA-208.86M
Net Income-194.94M
Diluted EPS-2.29

Balance Sheet

Total Cash272.53M
Total Cash/Share3.6
Total Debt25.02M
Total Debt/Equity0.07
Current Ratio3.8
Book Value Per Share4.13

Price History

52-Week Change86.92
52-Week High25.61
52-Week Low9.9
Moving Average 50 Days21.07
Moving Average 200 Days15.75

Statistics

Average Volume1.86M
Shares Outstanding86.48M
% Held by Institutions0.06

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A